Cassel Salpeter & Co. and its leadership team are routinely contacted by the news media to comment on investment banking, M&A and general trends affecting middle-market businesses.
https://www.casselsalpeter.com/wp-content/uploads/2022/07/Bio-Space-Logo.png576576Walker Matzkohttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngWalker Matzko2023-09-13 15:06:092023-09-15 15:28:43Why Biopharma Companies Buy Stock in One Another
https://www.casselsalpeter.com/wp-content/uploads/2015/11/Roar-MediaLogos-MergersAcquisitions-Square.jpg.jpg300300roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-09-04 17:25:402023-09-11 17:35:25Dealflow Continues to Drop, But Some are Optimistic for a Bounceback This Fall
Cassel Salpeter Healthcare Investment Banker Weighs IRA Impacts
South Florida investment bank managing director discusses future of biosimilars after IRA
https://www.casselsalpeter.com/wp-content/uploads/2022/07/Bio-Space-Logo.png576576roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-07-19 14:52:452023-07-20 15:02:59Humira Biosimilars and Others Face Uncertain Future Under IRA
Cassel Salpeter Healthcare Investment Banker Talks Mpox Vaccine
South Florida investment bank managing director considers viability of mpox vaccine development
https://www.casselsalpeter.com/wp-content/uploads/2023/07/Fierce-Biotech.png471471roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-07-18 19:28:392023-07-19 21:39:48Blue Water Biotech makes the case for better mpox vaccines, even at ‘hyperlow endemicity’
https://www.casselsalpeter.com/wp-content/uploads/2023/06/BHB_Image.jpg409409roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-07-05 17:07:442023-07-07 18:55:54‘We Don’t Have Enough of an Infrastructure’: Psychiatric Hospitals Buckling Under Historic Pressure
Cassel Salpeter Chairman and Cofounder on CARD Bankruptcy
South Florida investment banker James Cassel discusses industry impacts of autism center Ch. 11
https://www.casselsalpeter.com/wp-content/uploads/2023/06/BHB_Image.jpg409409roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-06-21 13:16:552023-06-27 18:40:12‘If There Is a Chilling Effect, It’ll Be Very Temporary’: What CARD’s Bankruptcy Means for the Autism Industry
South Florida Investment Bank Assists Global Cancer Therapy Creator in Bankruptcy
Cassel Salpeter provides investment banking services to biopharmaceutical company Athenex in Chapter 11
https://www.casselsalpeter.com/wp-content/uploads/2017/03/Notified-GlobeNewswire-Color-Large_377.jpeg600620roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-05-14 12:57:432023-05-16 13:09:39Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
https://www.casselsalpeter.com/wp-content/uploads/2023/03/image-70.png480480roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-03-14 18:06:432023-03-16 20:01:38Startup funding will be more competitive after Silicon Valley Bank collapse
https://www.casselsalpeter.com/wp-content/uploads/2020/03/Sunsentinel-logo-300x300-1.jpg300300roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-03-13 15:34:302023-03-15 15:50:31Banks seek to reassure South Florida depositors their accounts are safe
https://www.casselsalpeter.com/wp-content/uploads/2015/11/Roar-MediaLogos-MergersAcquisitions-Square.jpg.jpg300300adminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngadmin2023-03-03 18:56:142023-03-07 21:27:32Deal Opportunities Still Exist in the Lower Middle-Market
Committed to providing world-class independent investment banking services to middle-market and emerging growth companies, Cassel Salpeter is excited to announce the addition of proven financial industry professional Charles Davis, who joins the firm as an associate.
https://www.casselsalpeter.com/wp-content/uploads/2022/07/Bio-Space-Logo.png576576roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2023-01-16 17:20:312023-01-18 17:36:58How to Prepare if Your Company is Being Acquired
Miami Investment Banker Helps Creditors Receive Payment
Cassel Salpeter cofounder and chairman facilitates $6.9 million distribution to 3,750 creditors
https://www.casselsalpeter.com/wp-content/uploads/2017/03/Notified-GlobeNewswire-Color-Large_377.jpeg600620roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2022-12-22 11:32:592022-12-22 22:08:25Trustee Makes Further Distribution in 1 Global Capital LLC, 1 West Capital LLC, Bankruptcy Cases
Miami Investment Banker James Cassel Eyes Pressure on Unicorn Founders
Investment Banker James Cassel on Why Founders Leave After Their Companies Go Public
http://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.png00roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2022-11-23 15:40:552022-11-23 18:57:36Whether Fired or Tired, Young Guns Are Leaving Silicon Valley
https://www.casselsalpeter.com/wp-content/uploads/2022/07/Bio-Space-Logo.png576576roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2022-09-13 19:34:002022-09-13 19:34:45Moderna’s Second Act: is the Momentum Sustainable?
https://www.casselsalpeter.com/wp-content/uploads/2022/07/Bio-Space-Logo.png576576roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2022-07-26 17:51:202022-07-27 18:05:47mRNA’s Next Act: Cancer Vaccines and Gene Editing
Cassel Salpeter Healthcare Industry Investment Bankers Talk Future of Biotech Unicorns. South Florida investment bank managing directors weigh prospects for biotech financing ahead
https://www.casselsalpeter.com/wp-content/uploads/2022/07/Bio-Space-Logo.png576576roaradminhttp://www.casselsalpeter.com/wp-content/uploads/2021/05/CS-Logo-for-Assets-Post-10-Year-Branding_Website_04.28.21_Draft01.pngroaradmin2022-07-13 21:17:492022-07-13 21:17:49Will Biotech Unicorns Soon Be on The Endangered Species List?
Dry Powder Reserves Point to Insatiable Buyout Demand
/0 Comments/in In the News, News /by Walker MatzkoCassel Salpeter Chairman and Cofounder Talks 4th Quarter Deal Flow
South Florida investment banker James Cassel discusses factors driving midmarket M&A
Why Biopharma Companies Buy Stock in One Another
/in In the News /by Walker MatzkoCassel Salpeter Healthcare Investment Banker Considers IRA Impacts
South Florida investment bank managing director talks biologics R&D after IRA
Dealflow Continues to Drop, But Some are Optimistic for a Bounceback This Fall
/in In the News, News /by roaradminCassel Salpeter Chairman and Cofounder Talks 4th Quarter Deal Flow
South Florida investment banker James Cassel discusses factors driving midmarket M&A
IRA Creates Unintended Complications for Biologics
/in In the News /by roaradminCassel Salpeter Healthcare Investment Banker Considers IRA Impacts
South Florida investment bank managing director talks biologics R&D after IRA
Humira Biosimilars and Others Face Uncertain Future Under IRA
/in In the News /by roaradminCassel Salpeter Healthcare Investment Banker Weighs IRA Impacts
South Florida investment bank managing director discusses future of biosimilars after IRA
Blue Water Biotech makes the case for better mpox vaccines, even at ‘hyperlow endemicity’
/in In the News /by roaradminCassel Salpeter Healthcare Investment Banker Talks Mpox Vaccine
South Florida investment bank managing director considers viability of mpox vaccine development
‘We Don’t Have Enough of an Infrastructure’: Psychiatric Hospitals Buckling Under Historic Pressure
/in In the News, News /by roaradminCassel Salpeter Chairman and Cofounder Addresses Psychiatric Care Closings
South Florida investment banker James Cassel discusses what’s driving psychiatric services shutdowns
‘If There Is a Chilling Effect, It’ll Be Very Temporary’: What CARD’s Bankruptcy Means for the Autism Industry
/in In the News, News /by roaradminCassel Salpeter Chairman and Cofounder on CARD Bankruptcy
South Florida investment banker James Cassel discusses industry impacts of autism center Ch. 11
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
/in In the News /by roaradminSouth Florida Investment Bank Assists Global Cancer Therapy Creator in Bankruptcy
Cassel Salpeter provides investment banking services to biopharmaceutical company Athenex in Chapter 11
Startup funding will be more competitive after Silicon Valley Bank collapse
/in In the News, News /by roaradminCassel Salpeter Chairman on South Florida Tech Post-SVB Failure
South Florida investment bank founder James Cassel discusses future of South Florida tech economy
Banks seek to reassure South Florida depositors their accounts are safe
/in In the News, News /by roaradminCassel Salpeter Chairman and Cofounder on SVB Fallout
South Florida investment bank founder James Cassel discusses commercial lending post-SVB collapse
Deal Opportunities Still Exist in the Lower Middle-Market
/in In the News, News /by adminCassel Salpeter Chairman and Cofounder Talks Deals in the Lower Middle Market
South Florida investment banker James Cassel discusses M&A opportunities in a cautious marketplace
Cassel Salpeter & Co. Secures Debt Financing for Quick Shift Capital LLC
/in In the News /by roaradminCommitted to providing world-class independent investment banking services to middle-market and emerging growth companies, Cassel Salpeter is excited to announce the addition of proven financial industry professional Charles Davis, who joins the firm as an associate.
How to Prepare if Your Company is Being Acquired
/in In the News /by roaradminCassel Salpeter Healthcare Industry Investment Bankers On Getting Acquired
South Florida investment bank managing directors on best tips and practices following biotech acquisition
Trustee Makes Further Distribution in 1 Global Capital LLC, 1 West Capital LLC, Bankruptcy Cases
/in In the News /by roaradminMiami Investment Banker Helps Creditors Receive Payment
Cassel Salpeter cofounder and chairman facilitates $6.9 million distribution to 3,750 creditors
Whether Fired or Tired, Young Guns Are Leaving Silicon Valley
/in In the News, News /by roaradminMiami Investment Banker James Cassel Eyes Pressure on Unicorn Founders
Investment Banker James Cassel on Why Founders Leave After Their Companies Go Public
Moderna’s Second Act: is the Momentum Sustainable?
/in In the News /by roaradminThe potential for mRNA technology extends far beyond the COVID-19 vaccines that made it a household word.
Who’s Flying Now?
/in In the News /by roaradminMiami Investment Banking Firm Director Talks Changing Private Aviation Space
South Florida’s Cassel Salpeter Aviation Director discusses how companies are addressing changes in private aviation
mRNA’s Next Act: Cancer Vaccines and Gene Editing
/in In the News /by roaradminThe potential for mRNA technology extends far beyond the COVID-19 vaccines that made it a household word.
Will Biotech Unicorns Soon Be on The Endangered Species List?
/in In the News /by roaradminCassel Salpeter Healthcare Industry Investment Bankers Talk Future of Biotech Unicorns. South Florida investment bank managing directors weigh prospects for biotech financing ahead